0001209191-24-002098.txt : 20240123 0001209191-24-002098.hdr.sgml : 20240123 20240123172241 ACCESSION NUMBER: 0001209191-24-002098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240122 FILED AS OF DATE: 20240123 DATE AS OF CHANGE: 20240123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JAIN ABHINAV CENTRAL INDEX KEY: 0001981291 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 24553568 MAIL ADDRESS: STREET 1: C/O AYTU BIOPHARMA, INC. STREET 2: 373 INVERNESS PARKWAY, SUITE 206 CITY: ENGLEWOOD STATE: CO ZIP: 80112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TALPHERA, INC. CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1850 GATEWAY DRIVE STREET 2: SUITE 175 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 1850 GATEWAY DRIVE STREET 2: SUITE 175 CITY: SAN MATEO STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: ACELRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20080222 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-22 0 0001427925 TALPHERA, INC. TLPH 0001981291 JAIN ABHINAV C/O TALPHERA, INC. 1850 GATEWAY DRIVE, SUITE 175 SAN MATEO CA 94404 1 0 0 0 0 Common Stock 2024-01-22 4 A 0 871 0.00 A 871 D Stock Option (Right to Buy) 0.912 2024-01-22 4 A 0 5228 0.00 A 2034-01-22 Common Stock 5228 5228 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest in three equal consecutive annual installments on January 22, 2025, January 22, 2026 and January 22, 2027. The shares subject to the option vest as follows: 33% of the shares subject to the option vest on the one year anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 24 months. /s/ Martha Adler, Attorney-In-Fact 2024-01-23